Revisiting the Geographical Distribution of Thyroid Cancer Incidence in Fukushima Prefecture: Analysis of Data From the Second- and Third-round Thyroid Ultrasound Examination.

discrete survival analysis flexibly shaped spatial scan statistics maximized excess events test (MEET) thyroid cancer screening

Journal

Journal of epidemiology
ISSN: 1349-9092
Titre abrégé: J Epidemiol
Pays: Japan
ID NLM: 9607688

Informations de publication

Date de publication:
2022
Historique:
entrez: 4 12 2022
pubmed: 5 12 2022
medline: 7 12 2022
Statut: ppublish

Résumé

After the first-round (Preliminary Baseline Survey) ultrasound-based examination for thyroid cancer in response to the accident at the Fukushima Daiichi Nuclear Power Plant in 2011, two rounds of surveys (Full-scale Survey) have been carried out in Fukushima Prefecture. Using the data from these surveys, the geographical distribution of thyroid cancer incidence over 6 or 7 years after the disaster was examined. Children and adolescents who underwent the ultrasound-based examinations in the second- and/or third-round (Full-scale) survey in addition to the first-round survey were included. With a discrete survival model, we computed age, sex, and body mass index standardized incidence ratios (SIRs) for municipalities. Then, we employed spatial statistics to assess geographic clustering tendency in SIRs and Poisson regression to assess the association of SIRs with the municipal average absorbed dose to the thyroid gland at the 59-municipality level. Throughout the second- and third-round surveys, 99 thyroid cancer cases were diagnosed in the study population of 252,502 individuals. Both flexibly shaped spatial scan statistics and maximized excess events test did not detect statistically significant spatial clustering (P = 0.17 and 0.54, respectively). Poisson regression showed no significant dose-response relationship: the estimated relative risks of lowest, middle-low, middle-high, and highest areas were 1.16 (95% confidence interval [CI], 0.52-2.59), 0.55 (95% CI, 0.31-0.97), 1.05 (95% CI, 0.79-1.40), and 1.24 (95% CI, 0.89-1.74). There was no statistical support for geographic clustering or regional association with radiation dose measures of the thyroid cancer incidence in the cohort followed up to the third-round survey (fiscal years 2016-2017) in Fukushima Prefecture.

Sections du résumé

BACKGROUND
After the first-round (Preliminary Baseline Survey) ultrasound-based examination for thyroid cancer in response to the accident at the Fukushima Daiichi Nuclear Power Plant in 2011, two rounds of surveys (Full-scale Survey) have been carried out in Fukushima Prefecture. Using the data from these surveys, the geographical distribution of thyroid cancer incidence over 6 or 7 years after the disaster was examined.
METHODS
Children and adolescents who underwent the ultrasound-based examinations in the second- and/or third-round (Full-scale) survey in addition to the first-round survey were included. With a discrete survival model, we computed age, sex, and body mass index standardized incidence ratios (SIRs) for municipalities. Then, we employed spatial statistics to assess geographic clustering tendency in SIRs and Poisson regression to assess the association of SIRs with the municipal average absorbed dose to the thyroid gland at the 59-municipality level.
RESULTS
Throughout the second- and third-round surveys, 99 thyroid cancer cases were diagnosed in the study population of 252,502 individuals. Both flexibly shaped spatial scan statistics and maximized excess events test did not detect statistically significant spatial clustering (P = 0.17 and 0.54, respectively). Poisson regression showed no significant dose-response relationship: the estimated relative risks of lowest, middle-low, middle-high, and highest areas were 1.16 (95% confidence interval [CI], 0.52-2.59), 0.55 (95% CI, 0.31-0.97), 1.05 (95% CI, 0.79-1.40), and 1.24 (95% CI, 0.89-1.74).
CONCLUSION
There was no statistical support for geographic clustering or regional association with radiation dose measures of the thyroid cancer incidence in the cohort followed up to the third-round survey (fiscal years 2016-2017) in Fukushima Prefecture.

Identifiants

pubmed: 36464303
doi: 10.2188/jea.JE20210165
pmc: PMC9703926
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S76-S83

Références

Int J Cancer. 2017 Oct 15;141(8):1585-1588
pubmed: 28662277
Medicine (Baltimore). 2020 Jul 2;99(27):e20440
pubmed: 32629628
Epidemiology. 2018 Jul;29(4):e32-e34
pubmed: 29634592
Jpn J Clin Oncol. 2016 Mar;46(3):284-6
pubmed: 26755830
J Radiol Prot. 2020 Sep;40(3):924-927
pubmed: 32521526
Occup Environ Med. 2010 Jan;67(1):67-71
pubmed: 20029026
Pediatr Int. 2017 Sep;59(9):1002-1009
pubmed: 28608648
Int J Health Geogr. 2003 Dec 19;2(1):9
pubmed: 14687424
Endocr J. 2016;63(3):315-21
pubmed: 26924746
Arq Bras Endocrinol Metabol. 2007 Jul;51(5):748-62
pubmed: 17891238
Medicine (Baltimore). 2016 Aug;95(35):e4472
pubmed: 27583855
Environ Health Perspect. 2011 Jul;119(7):933-9
pubmed: 21406336
J Epidemiol. 2020 Jul 7;30(7):301-308
pubmed: 31204362
Sci Rep. 2018 Dec 5;8(1):17661
pubmed: 30518765
J Radiat Res. 2020 Mar 23;61(2):243-248
pubmed: 32030428
J Epidemiol. 2012;22(5):375-83
pubmed: 22955043
Epidemiology. 2016 May;27(3):316-22
pubmed: 26441345
Medicine (Baltimore). 2017 Dec;96(48):e8631
pubmed: 29310337
Medicine (Baltimore). 2019 Sep;98(37):e17165
pubmed: 31517868
Sci Rep. 2020 Mar 5;10(1):4074
pubmed: 32139763
Air Qual Atmos Health. 2012 Jun;5(2):203-216
pubmed: 22662023
Epidemiology. 2019 Nov;30(6):853-860
pubmed: 31259849
Stat Med. 2000 Jan 30;19(2):191-204
pubmed: 10641024
Br J Cancer. 2011 Jan 4;104(1):181-7
pubmed: 21102590
Int J Health Geogr. 2005 May 18;4:11
pubmed: 15904524

Auteurs

Tomoki Nakaya (T)

Graduate School of Environmental Studies, Tohoku University.
Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.

Kunihiko Takahashi (K)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Biostatistics, M&D Data Science Center, Tokyo Medical and Dental University.

Hideto Takahashi (H)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
National Institute of Public Health.

Seiji Yasumura (S)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Public Health, Fukushima Medical University School of Medicine.

Tetsuya Ohira (T)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Epidemiology, Fukushima Medical University School of Medicine.

Hiroki Shimura (H)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Laboratory Medicine, Fukushima Medical University School of Medicine.

Satoru Suzuki (S)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.

Satoshi Suzuki (S)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.

Manabu Iwadate (M)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Thyroid and Endocrinology, Fukushima Medical University School of Medicine.

Susumu Yokoya (S)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Thyroid and Endocrine Center, Fukushima Medical University.

Hitoshi Ohto (H)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.

Kenji Kamiya (K)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Research Institute for Radiation Biology and Medicine, Hiroshima University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH